Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Elite provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Hayato Tada practices in Kanazawa, Japan. Mr. Tada is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Familial Hypercholesterolemia, High Cholesterol, Sitosterolemia, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).

Robert Hegele practices in London, Canada. Hegele is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. Their top areas of expertise are Familial Hypertriglyceridemia, High Cholesterol, Apolipoprotein C2 Deficiency, and Familial Lipoprotein Lipase Deficiency.

Raul Santos practices in Sao Paulo, Brazil. Mr. Santos is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Familial Hypercholesterolemia, High Cholesterol, Heterozygous Familial Hypercholesterolemia (HeFH), and Homozygous Familial Hypercholesterolemia (HoFH).

Daniel Rader is a Cardiologist and a Medical Genetics provider in Philadelphia, Pennsylvania. Dr. Rader is rated as an Elite provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Homozygous Familial Hypercholesterolemia (HoFH), Coronary Heart Disease, Atherosclerosis, and Heart Transplant. Dr. Rader is currently accepting new patients.

Mariko Shiba-Harada practices in Osaka, Japan. Ms. Shiba-Harada is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. Her top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, High Cholesterol, and Homozygous Familial Hypercholesterolemia (HoFH).

Peter Toth is a primary care provider, practicing in Family Medicine in Milledgeville, Illinois. Dr. Toth is rated as an Elite provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Atherosclerosis, Familial Hypertriglyceridemia, Hypertension, and Percutaneous Coronary Intervention (PCI). Dr. Toth is currently accepting new patients.

Marcello Arca practices in Rome, Italy. Mr. Arca is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, High Cholesterol, and Familial Hypertriglyceridemia.

Erik Stroes practices in Amsterdam, Netherlands. Mr. Stroes is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, Atherosclerosis, and Carotid Artery Surgery.

Maurizio Averna practices in Palermo, Italy. Mr. Averna is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Homozygous Familial Hypercholesterolemia (HoFH), Familial Hypercholesterolemia, and Familial Hypobetalipoproteinemia.

Dirk Blom practices in Cape Town, South Africa. Mr. Blom is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), Familial Hypercholesterolemia, High Cholesterol, Defective Apolipoprotein B-100, and Hormone Replacement Therapy (HRT).

Maciej Banach practices in Plock, Poland. Mr. Banach is rated as an Elite expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Hypertension, Atherosclerosis, Kidney Transplant, and Heart Bypass Surgery.

Robert Pordy is a primary care provider, practicing in Internal Medicine in New York, New York. Dr. Pordy is rated as a Distinguished provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, Familial Hypercholesterolemia, and Acute Coronary Syndrome.

Pedro Mata practices in Majadahonda, Spain. Mr. Mata is rated as a Distinguished expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Familial Hypercholesterolemia, High Cholesterol, Heterozygous Familial Hypercholesterolemia (HeFH), and Defective Apolipoprotein B-100.

Gerald Hovingh practices in Amsterdam, Netherlands. Mr. Hovingh is rated as a Distinguished expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Defective Apolipoprotein B-100, Familial Hypercholesterolemia, High Cholesterol, and Heterozygous Familial Hypercholesterolemia (HeFH).

Vera Bittner is a Cardiologist in Birmingham,, Alabama. Dr. Bittner is rated as a Distinguished provider by MediFind in the treatment of Hyperlipidemia Type 3. Her top areas of expertise are Acute Coronary Syndrome, Coronary Heart Disease, Unstable Angina, Heart Bypass Surgery, and Cardiac Ablation.

Luis Masana practices in Reus, Spain. Masana is rated as a Distinguished expert by MediFind in the treatment of Hyperlipidemia Type 3. Their top areas of expertise are High Cholesterol, Familial Hypercholesterolemia, Defective Apolipoprotein B-100, and Homozygous Familial Hypercholesterolemia (HoFH).

Frank Visseren practices in Utrecht, Netherlands. Mr. Visseren is rated as a Distinguished expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are Hyperlipidemia Type 3, Pseudoxanthoma Elasticum, Atherosclerosis, Leg or Foot Amputation, and Heart Bypass Surgery.

Richard Ceska practices in Prague, Czech Republic. Mr. Ceska is rated as a Distinguished expert by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Defective Apolipoprotein B-100, Familial Hypercholesterolemia, and Atherosclerosis.

Jose Diaz is a primary care provider, practicing in Internal Medicine in Miami, Florida. Dr. Diaz is rated as a Distinguished provider by MediFind in the treatment of Hyperlipidemia Type 3. His top areas of expertise are High Cholesterol, Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, and Defective Apolipoprotein B-100. Dr. Diaz is currently accepting new patients.